Close Menu

NEW YORK – The GenomeWeb Index rose a fraction of a percent in October, erasing part of the losses it saw in September and August.

The index underperformed the Dow Jones Industrial Average, the Nasdaq, and the Nasdaq Biotechnology Index, which gained .5 percent, nearly 4 percent, and nearly 8 percent, respectively. Individual stock performance in the GenomeWeb Index was mostly negative as 18 of the 32 stocks saw losses and 14 saw gains.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.